iPLATO Hub to Help Government Boost Uptake of NHS Health Checks

iPLATO HealthcareiPLATO Healthcare, a UK leader in cloud based mHealth and Analytics, welcomes the new government mandate to re-launch NHS Health Checks to reach 15 million patients over the next 5 years. In a number of trials in recent years the iPLATO service has proven to help engage target patients around NHS Health Checks and cost effectively reach screening targets. iPLATO states its commitment to help Public Health England reach its ambitious target through further development to its iPLATO Hub product to include letter and phone calls in addition to its existing mix of digital engagement - SMS, Apps and Video.

"NHS Health Checks has been a popular campaign for our Public Health and GP Practice partners for some time," says Tobias Alpsten, CEO of iPLATO. "Practices use iPLATO to engage patients and invite for NHS Health Checks every year. Using iPLATO Hub, local and regional Public Health teams can tap into this existing communication capability and transform overall performance through very sophisticated multi-channel campaigns. This is a huge step up from traditionally laborious processes for informing patients about NHS Health Checks and inviting them to book an appointment."

Kim, IT Manager at Brondesbury Medical Centre, an iPLATO user says, "Mobile phones are used by most of our patients and so text messaging is an effective way to communicate with them especially around NHS Health Checks. This service has the potential to significantly increase the number of patients attending clinics as well as saving on surgery administration costs."

In a document laying out its priorities for 2013-16 Public Health England said all 40 to 74 year olds will be offered health checks, which were introduced in 2009 with the aim of preventing heart disease, stroke, diabetes, kidney disease and certain types of dementia. Public Health England said one of its priorities was to reduce preventable deaths and to do this it would 'support people to live healthier lives by implementing NHS Health Checks to 15 million eligible people.'

Related news articles:

About iPLATO
iPLATO Healthcare is British innovation company. iPLATO’s evidence based mobile health solutions have proven to improve patient access to healthcare, to enable powerful health promotion targeted at people at risk and to support people with long term conditions.

Serving millions of patients and thousands of healthcare professionals every day iPLATO has emerged as the leader in mobile health. Across this network the company is running campaigns to promote smoking cessation, weight loss, childhood immunisation and pandemic awareness as well as mobile disease management services for people with diabetes, hypertension, epilepsy and HIV.

iPLATO Healthcare's mission is to, in partnership with clinicians, help healthcare commissioners transform patient care through cloud based mHealth and Analytics.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

Standing Up for Health Tech and SMEs: Sh…

AS the new chair of the health and social care council at techUK, Shane Tickell talked to Highland Marketing about his determination to support small and innovative companies, by having...